How much is atbtherapeutics worth in 2026?

atbtherapeutics has a current valuation of N/A based on their Later Stage VC round and secondary market data.

How much funding has atbtherapeutics raised?

atbtherapeutics has raised $66.1M in total funding across 0 funding rounds.

atbtherapeutics

Website

atbtherapeutics valuation and funding history | Last updated: October 1, 2024

Current Valuation

N/A

As of October 1, 2024

Total Funding Raised

$66.1M

Last Round

Later Stage VC

$60.0M

Last Funding

Oct 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

atbtherapeutics is currently valued at N/A as of October 1, 2024. The company has raised a total of $66.1M in funding.

Track atbtherapeutics Valuation Updates

Get notified when atbtherapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for atbtherapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock atbtherapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is atbtherapeutics Worth in 2026?

atbtherapeutics is a leading private company in the technology sector. Track atbtherapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How atbtherapeutics Valuation is Determined

Private company valuations like atbtherapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.